ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 21 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,893 | -94.1% | 1,100 | -91.9% | 0.00% | – |
| Q1 2023 | $49,136 | -6.7% | 13,499 | 0.0% | 0.00% | – |
| Q4 2022 | $52,646 | +2532.3% | 13,499 | +2689.0% | 0.00% | – |
| Q3 2022 | $2,000 | -84.6% | 484 | -83.2% | 0.00% | – |
| Q2 2022 | $13,000 | -89.7% | 2,884 | -87.2% | 0.00% | – |
| Q1 2022 | $126,000 | – | 22,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lee Capital Holdings LLC | 11,805 | $46,482 | 0.07% |
| Susquehanna International Group Ltd. | 18,887 | $72,073 | 0.03% |
| Compagnie Lombard Odier SCmA | 50,000 | $190,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $50,700 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 647 | $2,547 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11,746 | $46,250 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 13,499 | $52,646 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $40 | 0.00% |